Melatonin لـ صعوبة بدء النوم
A الأدلة تُظهر تجارب سريرية كبيرة متعددة باستمرار فوائد ملحوظة.بناءً على 30 دراسة (7 meta-analyses, 6 RCTs) بمشاركة 10,634 مشاركًا إجمالاً. 19/30 دراسة تُظهر تأثيرات إيجابية.
الخلاصة
Melatonin is strongly supported by research as a supplement that may help you fall asleep faster, which is one of its best-established benefits.
- 30 studies with 10,634 participants, including 7 meta-analyses and 6 RCTs
- About 63% of studies confirm melatonin helps reduce the time it takes to fall asleep
- Dose-response meta-analyses have helped identify effective dosing ranges
- Recognized in clinical guidelines for both adults and children
Key Study Findings
Key Statistics
30
الدراسات
10634
المشاركون
Positive
التقييم
Referenced Papers
Dosage & Usage
mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units
الجرعات الشائعة
- general:
- 0.5-3 mg, 30-60 min before bed
- jetlag:
- 0.5-5 mg
الحد الأعلى: No established UL; 5 mg typically considered maximum
الجرعات المدروسة في الأبحاث
| الجرعة | المدة | التأثير | ن |
|---|---|---|---|
| Melatonin (various doses), CBT-I (behavioral), pharmacologic options (z-drugs, other) | -- | Positive | -- |
| Mediterranean diet (high adherence vs. low adherence); polyphenols, omega-3, fiber as key components | -- | Positive | -- |
| None | -- | Positive | -- |
| not specified (intragastric administration) | -- | Positive | -- |
| melatonin (various doses, peak efficacy at 4 mg/day) | -- | Positive | 1689 |
| 0.5 g/kg and 1.0 g/kg intragastrically | 4 weeks | Positive | -- |
| low-dose melatonin administered 30-60 min before bedtime | -- | Positive | -- |
| variable (prolonged-release melatonin; ramelteon standard doses) | -- | Positive | 4875 |
أفضل وقت للتناول: 30-60 minutes before bed
Safety & Side Effects
الآثار الجانبية المُبلّغ عنها
- ⚠ Daytime drowsiness
- ⚠ Headache
- ⚠ Dizziness
- ⚠ Nausea
- ⚠ Vivid dreams or nightmares
التفاعلات المعروفة
- ● Blood thinners (warfarin) — may increase bleeding risk
- ● Immunosuppressants — melatonin may stimulate immune function
- ● Diabetes medications — may affect blood sugar levels
- ● Sedatives and CNS depressants — additive drowsiness
الحد الأقصى المسموح به: No established UL; 5 mg typically considered maximum
استشر مقدم الرعاية الصحية دائماً قبل البدء بأي مكمل غذائي.
Frequently Asked Questions
Does Melatonin help with صعوبة بدء النوم?
How much Melatonin should I take for صعوبة بدء النوم?
Are there side effects of Melatonin?
How strong is the evidence for Melatonin and صعوبة بدء النوم?
Related Evidence
مكونات أخرى لـ صعوبة بدء النوم
References
- [1] Rayan Kteish et al.. Pediatr Rev. 2026. Pediatric Insomnia. doi:10.1542/pir.2024-006687 PubMed
- [2] Kacper Żełabowski et al.. Molecules. 2025. The Efficacy of Melatonergic Receptor Agonists Used in Clinical Practice in Insomnia Treatment: Melatonin, Tasimelteon, Ramelteon, Agomelatine, and Selected Herbs. doi:10.3390/molecules30183814 PubMed
- [3] Tatiana Palotta Minari et al.. Sleep Breath. 2025. Unraveling the connection between the Mediterranean diet and sleep health: from biological mechanisms to clinical implications. doi:10.1007/s11325-025-03546-2 PubMed
- [4] Francy Cruz-Sanabria et al.. J Pineal Res. 2024. Optimizing the Time and Dose of Melatonin as a Sleep-Promoting Drug: A Systematic Review of Randomized Controlled Trials and Dose-Response … doi:10.1111/jpi.12985 PubMed
- [5] Oliviero Bruni et al.. Eur J Pediatr. 2024. European expert guidance on management of sleep onset insomnia and melatonin use in typically developing children. doi:10.1007/s00431-024-05556-w PubMed
- [6] Haiqin Ren et al.. J Ethnopharmacol. 2024. The therapeutic potential of Ziziphi Spinosae Semen and Polygalae Radix in insomnia management: Insights from gut microbiota and serum metabolomics … doi:10.1016/j.jep.2024.118255 PubMed
- [7] Tian-Ji Xia et al.. J Ethnopharmacol. 2024. Shen Yuan extract exerts a hypnotic effect via the tryptophan/5-hydroxytryptamine/melatonin pathway in mice. doi:10.1016/j.jep.2024.117992 PubMed
- [8] Julia Maruani et al.. J Sleep Res. 2023. Efficacy of melatonin and ramelteon for the acute and long-term management of insomnia disorder in adults: A systematic review and … doi:10.1111/jsr.13939 PubMed
- [9] Kyungseon Choi et al.. Sleep Med Rev. 2022. Efficacy of melatonin for chronic insomnia: Systematic reviews and meta-analyses. doi:10.1016/j.smrv.2022.101692 PubMed
- [10] Bárbara Carriedo-Diez et al.. Int J Environ Res Public Health. 2022. The Effects of the Exogenous Melatonin on Shift Work Sleep Disorder in Health Personnel: A Systematic Review. doi:10.3390/ijerph191610199 PubMed
- [11] Landon Hester et al.. Chronobiol Int. 2021. Evening wear of blue-blocking glasses for sleep and mood disorders: a systematic review. doi:10.1080/07420528.2021.1930029 PubMed
- [12] Huajun Xu et al.. Sleep Med. 2020. Efficacy of melatonin for sleep disturbance in middle-aged primary insomnia: a double-blind, randomised clinical trial. doi:10.1016/j.sleep.2020.10.018 PubMed
- [13] Patrick Lemoine et al.. Complement Ther Med. 2019. A combination of melatonin, vitamin B6 and medicinal plants in the treatment of mild-to-moderate insomnia: A prospective pilot study. doi:10.1016/j.ctim.2019.05.024 PubMed
- [14] Athanasios Maras et al.. J Child Adolesc Psychopharmacol. 2018. Long-Term Efficacy and Safety of Pediatric Prolonged-Release Melatonin for Insomnia in Children with Autism Spectrum Disorder. doi:10.1089/cap.2018.0020 PubMed
- [15] Vivien C Abad et al.. Drugs Aging. 2018. Insomnia in Elderly Patients: Recommendations for Pharmacological Management. doi:10.1007/s40266-018-0569-8 PubMed
- [16] Michael J Sateia et al.. J Clin Sleep Med. 2017. Clinical Practice Guideline for the Pharmacologic Treatment of Chronic Insomnia in Adults: An American Academy of Sleep Medicine Clinical Practice … doi:10.5664/jcsm.6470 PubMed
- [17] Paul Gringras et al.. J Am Acad Child Adolesc Psychiatry. 2017. Efficacy and Safety of Pediatric Prolonged-Release Melatonin for Insomnia in Children With Autism Spectrum Disorder. doi:10.1016/j.jaac.2017.09.414 PubMed
- [18] Milena Pavlova. Continuum (Minneap Minn). 2017. Circadian Rhythm Sleep-Wake Disorders. doi:10.1212/CON.0000000000000499 PubMed
- [19] Eric Matheson et al.. Am Fam Physician. 2017. Insomnia: Pharmacologic Therapy. PubMed
- [20] Yvan Touitou et al.. J Physiol Paris. 2016. Disruption of adolescents' circadian clock: The vicious circle of media use, exposure to light at night, sleep loss and risk … doi:10.1016/j.jphysparis.2017.05.001 PubMed
- [21] Juha Liira et al.. Cochrane Database Syst Rev. 2014. Pharmacological interventions for sleepiness and sleep disturbances caused by shift work. doi:10.1002/14651858.CD009776.pub2 PubMed
- [22] Eduardo Ferracioli-Oda et al.. PLoS One. 2013. Meta-analysis: melatonin for the treatment of primary sleep disorders. doi:10.1371/journal.pone.0063773 PubMed
- [23] Phyllis C Zee et al.. Continuum (Minneap Minn). 2013. Circadian rhythm abnormalities. doi:10.1212/01.CON.0000427209.21177.aa PubMed
- [24] Jessica R Barrett et al.. J Child Adolesc Psychopharmacol. 2013. To sleep or not to sleep: a systematic review of the literature of pharmacological treatments of insomnia in children and … doi:10.1089/cap.2013.0059 PubMed
- [25] Daniel P Cardinali et al.. J Pineal Res. 2012. Melatonin and its analogs in insomnia and depression. doi:10.1111/j.1600-079X.2011.00962.x PubMed
- [26] Wilfred R Pigeon et al.. J Med Food. 2010. Effects of a tart cherry juice beverage on the sleep of older adults with insomnia: a pilot study. doi:10.1089/jmf.2009.0096 PubMed
- [27] Michael J Sateia et al.. Sleep Med Rev. 2008. Efficacy and clinical safety of ramelteon: an evidence-based review. doi:10.1016/j.smrv.2007.12.005 PubMed
- [28] Louis J Mini et al.. Am J Geriatr Pharmacother. 2007. Self-reported efficacy and tolerability of ramelteon 8 mg in older adults experiencing severe sleep-onset difficulty. doi:10.1016/j.amjopharm.2007.09.004 PubMed
- [29] Daniel P Cardinali et al.. Neuro Endocrinol Lett. 2002. Melatonin in sleep disorders and jet-lag. PubMed
- [30] C M Ellis et al.. J Sleep Res. 1996. Melatonin and insomnia. doi:10.1046/j.1365-2869.1996.00003.x PubMed
إخلاء مسؤولية FDA: لم تُقيَّم هذه البيانات من قبل إدارة الغذاء والدواء (FDA). لا تهدف المنتجات والمعلومات الواردة في هذا الموقع إلى تشخيص أو علاج أو شفاء أو الوقاية من أي مرض. تستند تقييمات الأدلة المعروضة إلى تحليلنا للأبحاث المحكّمة المنشورة ولا تُشكّل نصيحة طبية. استشر مقدم الرعاية الصحية دائماً قبل البدء بأي نظام مكملات.